HBIO 2.11 (+0.48%)
US4169061052Medical Devices & InstrumentsMedical Instruments & Supplies

Harvard Bioscience (HBIO) Stock Highlights

2.11 | +0.48%
2024-12-21 06:47:24
Harvard Bioscience Inc is a US-based developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America and Europe, it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The majority of its revenue comes from the United States.

Statistics

Range Today
2.06 2.15
Volume Today 322.3K
Range 1 Year
1.99 5.56
Volume 1 Year 30.85M
Range 3 Year
1.98 7.36
Volume 3 Year 118.02M
Range 10 Year
1.39 8.75
Volume 10 Year 396.85M

Highlights

Market Capitalization 112.08M (small)
Floating Shares 38.22M
Current Price 2.11
Price To Earnings -8.89
Price To Revenue 1.59
Price To Book 1.53
Earnings Per Share -0.27
Payout Ratio 0%

Performance

Latest +0.48%
1 Month +1.93%
3 Months -22.43%
6 Months -28.47%
1 Year -57.72%
3 Years -68.46%
5 Years -27.24%
10 Years -59.27%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.